Related Experiment Video

Updated: May 20, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Effects of 3β-acethyl tormentic acid (3ATA) on ABCC proteins activity

Gleice Da Graça Rocha1, Marisol Simões1, Rodrigo Rodrigues Oliveira2

  • 1Laboratory of Cellular Immunology, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro 21949-900, RJ, Brazil.

International Journal of Molecular Sciences
|July 28, 2012
PubMed

Insights

3β-acetyl tormentic acid (3ATA) strongly inhibits Multidrug Resistance-associated Protein 1 (MRP1/ABCC1), offering potential as a tool for studying ABCC proteins or as a cancer therapy co-adjuvant.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cancer Research

Background:

  • Multidrug resistance (MDR) is a primary cause of chemotherapy failure and cancer relapse.
  • ATP-binding cassette (ABC) transporter proteins mediate active drug efflux, a key mechanism in MDR.
  • Identifying inhibitors of ABC transporters is crucial for overcoming MDR.

Purpose of the Study:

  • To investigate the inhibitory effects of 3β-acetyl tormentic acid (3ATA) on ABC transporter activity.
  • To evaluate 3ATA's potential as a pharmacological inhibitor for specific ABC transporters, particularly MRP1/ABCC1.

Main Methods:

  • Assessing 3ATA's effect on P-gp/ABCB1 activity.
  • Evaluating 3ATA's inhibition of MRP1/ABCC1 in B16/F10 and Ma104 cell lines.
  • Testing 3ATA's activity on other MRP/ABCC transporters (MRP1-5, ABCC2, ABCC3, ABCC4) using various cell lines.

Main Results:

  • 3ATA showed no effect on P-gp/ABCB1 activity.
  • 3ATA strongly inhibited MRP1/ABCC1 activity, with potency comparable or superior to MK571 in specific cell lines.
  • 3ATA demonstrated lower inhibitory effects on other tested ABCC transporters (ABCC2, ABCC3, ABCC4) and suggested limited inhibition of MRP1-5.

Conclusions:

  • 3ATA is identified as a novel inhibitor of the ABCC transporter family, with a notable effect on MRP1/ABCC1.
  • 3ATA holds potential as a valuable tool for researching MRP/ABCC protein functions.
  • 3ATA may serve as a co-adjuvant in treating multidrug-resistant tumors.
Keywords:
3β-acetyl tormentic acidABC transportersABCC transporter inhibitormultidrug resistancetriterpenes

More Related Videos

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase11:01

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase

Published on: November 23, 2016

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...